Pangan AL

No ORCID on file · 1 paper in corpus · active 2012
2012
Modern rheumatology ·doi:10.1007/s10165-011-0557-x

We evaluated the efficacy, pharmacokinetics, and safety of adalimumab in Japanese patients with active ankylosing spondylitis (AS) who had an inadequate response to, or who were intolerant of, treatment with ≥1 nonsteroidal anti-inflammator…